Conclusion: These results provide further evidence that NLRP3 and IL-1β targeting could represent an effective strategy in this disease and suggest a mechanistic explanation for the strong inflammatory manifestations associated to COVID-19. The gene discussed is IL1B; the disease is COVID-19.